Percentage of residents on antipsychotics without a diagnosis of psychosis.

Residents who received antipsychotic medication on one or more days in the seven days prior to their target assessment.

All residents.

1. Residents who are end-stage disease (<6 months to live) or receiving hospice care
2. Residents who have a diagnosis of schizophrenia or Huntington's chorea or
3. Experienced hallucinations or delusions in 7 days prior to assessment.

Direct Standardisation, Indirect Standardisation. Standard Population: 3,000 facilities in 6 U.S. states and 92 residential care facilities and continuing care hospitals in Ontario and Nova Scotia. Individual Covariates: Motor agitation; moderate/impaired decision-making problem; long-term memory problem; Cognitive Performance Scale; combination Alzheimer's disease/other dementia; age younger than 65.

Facility-Level Stratification: Case Mix Index.

Data availability 2017-21. Resident Assessment Instrument–Minimum Data Set 2.0 (RAI-MDS 2.0) and submitted to the Continuing Care Reporting System (CCRS), or using the interRAI Long-Term Care Facilities (interRAI LTCF) assessment and submitted to the Integrated interRAI Reporting System (IRRS).

Publicly reported at national and provincial/territory level as part of national Continuing Care Reporting System (CCRS), quarterly. Also includes reporting at region, LTCF, corporation, and sector level (not public). The CCRS quality indicators use 4 rolling quarters of data for calculations in order to have a sufficient number of assessments for risk adjustment. Since residents are assessed on a quarterly basis, each resident can contribute to the indicator up to 4 times.

www.cihi.ca/en/topics/long-term-care/indicators

www.cihi.ca/en/indicators/potentially-inappropriate-use-of-antipsychotics-in-long-term-care